Details

NameSymbolSector
CONCORD DRUGS LIMITEDCONCORDPharmaceuticals
Open
77.34
High
81.88
Low
77.34
Close
81.81
Volume
3526
Exchange
bse
Time
15-Jun-2026

Outlook

Score:  

0.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Concord Drugs is  
Marubozu
Estimated Stoploss of Concord Drugs is ₹  
77.34
Concord Drugs has a  
Bullishℹ
 pattern. 
Formation of  
Marubozu
 candle pattern indicates Concord Drugs has chances of  
Continuationℹ
 of the current trend. 

Trend

Concord Drugs is in  
Sideways trendℹ
. 
Price of Concord Drugs is  
Upℹ
 by  

1.44

%. 
Target
Buy @ 

68.96

Sell @ 

88.92

Current @ 

81.81

Volume

The trade volumes of Concord Drugs have become  
Deficientℹ
Though the volume trend for Concord Drugs appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Concord Drugs is  

Down

 by  

29.8

% 

Valuation

The current market price of Concord Drugs is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 65cr and total assets worth ₹ 65cr, the balance sheet of Concord Drugs is:  
Balancedℹ
. 
Cashflow
Concord Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 3cr earned in operatingℹ
33.33% i.e. ₹ 2cr spent in investingℹ
16.67% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Concord Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

0% in operatingℹ
100% i.e. ₹ 1cr spent in investingℹ
0% in financingℹ
0% in otherℹ
Income
The income of Concord Drugs is  

₹ 10cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Concord Drugs Losses increased by:  

0

% and Income is Down by:  

23.08

% 

(*Sep 2025)

The income of Concord Drugs is  

₹ 13cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Concord Drugs Losses increased by:  

0

% and Income is Up by:  

30

% 

(*Jun 2025)

The income of Concord Drugs is  

₹ 10cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Concord Drugs Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.